CYCC logo

Cyclacel Pharmaceuticals (CYCC) Long Term Debt

Annual Long Term Debt

$37.00 K
-$69.00 K-65.09%

December 31, 2023


Summary


Performance

CYCC Long Term Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCYCCbalance sheetmetrics:

Quarterly Long Term Debt

$0.00
-$5000.00-100.00%

September 30, 2024


Summary


Performance

CYCC Quarterly Long Term Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCYCCbalance sheetmetrics:

Long Term Debt Formula

Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt

CYCC Long Term Debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-65.1%-100.0%
3 y3 years-96.5%-100.0%
5 y5 years+100.0%-100.0%

CYCC Long Term Debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-65.1%+23.3%-100.0%at low
5 y5-year-96.9%+23.3%-100.0%at low
alltimeall time-98.6%-100.0%-100.0%at low

Cyclacel Pharmaceuticals Long Term Debt History

DateAnnualQuarterly
Sep 2024
-
$0.00(-100.0%)
Jun 2024
-
$5000.00(-76.2%)
Mar 2024
-
$21.00 K(-43.2%)
Dec 2023
$37.00 K(-65.1%)
$37.00 K(-28.8%)
Sep 2023
-
$52.00 K(-21.2%)
Jun 2023
-
$66.00 K(-17.5%)
Mar 2023
-
$80.00 K(-24.5%)
Dec 2022
$106.00 K(+253.3%)
$106.00 K(-0.9%)
Sep 2022
-
$107.00 K(-5.3%)
Jun 2022
-
$113.00 K(+653.3%)
Mar 2022
-
$15.00 K(-50.0%)
Dec 2021
$30.00 K(-97.2%)
$30.00 K(-31.8%)
Sep 2021
-
$44.00 K(>+9900.0%)
Jun 2021
-
$0.00(-100.0%)
Mar 2021
-
$996.00 K(-5.8%)
Dec 2020
$1.06 M
$1.06 M(-0.6%)
Sep 2020
-
$1.06 M(-1.7%)
Jun 2020
-
$1.08 M(+0.7%)
DateAnnualQuarterly
Mar 2020
-
$1.07 M(-9.9%)
Dec 2019
$1.19 M(>+9900.0%)
$1.19 M(+3.2%)
Sep 2019
-
$1.15 M(-6.4%)
Jun 2019
-
$1.23 M(-16.0%)
Mar 2019
-
$1.47 M(>+9900.0%)
Dec 2018
$0.00(-100.0%)
$0.00(-100.0%)
Mar 2009
-
$637.00 K(+1.8%)
Dec 2008
$626.00 K(+702.6%)
$626.00 K(+3812.5%)
Mar 2006
-
$16.00 K(-79.5%)
Dec 2005
$78.00 K(-97.1%)
$78.00 K(-92.4%)
Sep 2005
-
$1.03 M(-62.4%)
Jun 2005
-
$2.73 M(+7.1%)
Mar 2005
-
$2.55 M(-4.9%)
Dec 2004
$2.68 M(+169.7%)
$2.68 M(+24.0%)
Sep 2004
-
$2.16 M(+77.0%)
Jun 2004
-
$1.22 M(+5.9%)
Mar 2004
-
$1.15 M(+16.0%)
Dec 2003
$993.00 K
$993.00 K

FAQ

  • What is Cyclacel Pharmaceuticals annual long term debt?
  • What is the all time high annual long term debt for Cyclacel Pharmaceuticals?
  • What is Cyclacel Pharmaceuticals annual long term debt year-on-year change?
  • What is Cyclacel Pharmaceuticals quarterly long term debt?
  • What is the all time high quarterly long term debt for Cyclacel Pharmaceuticals?
  • What is Cyclacel Pharmaceuticals quarterly long term debt year-on-year change?

What is Cyclacel Pharmaceuticals annual long term debt?

The current annual long term debt of CYCC is $37.00 K

What is the all time high annual long term debt for Cyclacel Pharmaceuticals?

Cyclacel Pharmaceuticals all-time high annual long term debt is $2.68 M

What is Cyclacel Pharmaceuticals annual long term debt year-on-year change?

Over the past year, CYCC annual long term debt has changed by -$69.00 K (-65.09%)

What is Cyclacel Pharmaceuticals quarterly long term debt?

The current quarterly long term debt of CYCC is $0.00

What is the all time high quarterly long term debt for Cyclacel Pharmaceuticals?

Cyclacel Pharmaceuticals all-time high quarterly long term debt is $2.73 M

What is Cyclacel Pharmaceuticals quarterly long term debt year-on-year change?

Over the past year, CYCC quarterly long term debt has changed by -$37.00 K (-100.00%)